What is a pregnancy registry and what is the purpose of this registry?
A pregnancy registry is a voluntary prospective program designed to collect and evaluate medical information on pregnancies and outcomes reported, following exposure to a pharmaceutical product. Since there is little data regarding pregnancies exposed to ulipristal 30 mg, the collection of further data has been requested by European Health Authorities to continuously monitor the safety profile of ulipristal during pregnancy. The aforementioned companies established this registry to collect information on any pregnancy exposed to ulipristal 30 mg, e.g. unrecognized pregnancy before intake, or treatment failure.
It is important to know that your identity and the identity of your patient will remain strictly confidential and the personal/professional information will only be known to the electronic system. Your email address will also be requested and will be used only within the electronic system, through which you will receive automated emails that will allow you to complete additional information in the online questionnaire.
Why have I been approached about this registry?
If you have been contacted either via the electronic system based on information provided by a pregnant woman that has been exposed to ulipristal and is your patient, the woman in question has provided us with your contact details and has given her consent for us to request follow-up data on her pregnancy directly from you.